FMC (FMC) director gains 107 shares via dividend equivalent rights

Rhea-AI Filing Summary

FMC Corp director Johnson KLynne acquired 107 shares of common stock as a stock-based award. The shares were issued at no cash cost pursuant to dividend equivalent rights tied to vested restricted stock units held by the director. Following this award, Johnson directly holds 35,176 FMC common shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Johnson KLynne

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	107	$0.00	--

Holdings After Transaction: Common Stock — 35,176 shares (Direct)

Footnotes (1)

1. [object Object]

Key Figures

Shares awarded: 107 shares Post-transaction holdings: 35,176 shares Award price per share: $0.0000 per share

3 metrics

Shares awarded 107 shares Common stock granted via dividend equivalent rights on vested RSUs

Post-transaction holdings 35,176 shares FMC common stock directly held by Johnson KLynne after award

Award price per share $0.0000 per share Reported transaction price for the 107 awarded shares

Key Terms

dividend equivalent rights, restricted stock units, Form 4

3 terms

dividend equivalent rights financial

"These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units"

Dividend equivalent rights are promises that mirror the cash payments shareholders get from a company’s profits, but they are paid to holders of certain awards (like stock options or restricted stock units) rather than to actual shares. Think of them as a paycheck top‑up that matches dividends while the award is not yet a real stock, and they matter to investors because they add to employee compensation costs and potential share dilution, affecting company profitability and per‑share value.

restricted stock units financial

"dividend equivalent rights in connection with vested restricted stock units held by the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

Form 4 regulatory

"INSIDER FILING DATA (Form 4):"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Johnson KLynne

(Last) (First) (Middle)

FMC CORPORATION

2929 WALNUT STREET

(Street)

PHILADELPHIA PENNSYLVANIA 19104

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
FMC CORP [ FMC ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/16/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/16/2026		A		107(1)	A	$0	35,176	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. These shares were issued pursuant to dividend equivalent rights in connection with vested restricted stock units held by the reporting person.

	/s/ Sara Ponessa, attorney in fact for K'Lynne Johnson	04/17/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What insider transaction did FMC (FMC) disclose for Johnson KLynne?

FMC disclosed that director Johnson KLynne received 107 shares of common stock as a stock-based award. The shares were issued via dividend equivalent rights connected to vested restricted stock units and involved no cash purchase on the open market.

Was the FMC (FMC) insider transaction a stock purchase or an award?

The transaction was an award, not a market purchase. Johnson KLynne acquired 107 FMC common shares through dividend equivalent rights related to vested restricted stock units, a form of equity compensation rather than an open-market buy or sell transaction.

How many FMC (FMC) shares does Johnson KLynne hold after this Form 4?

After the reported award, director Johnson KLynne directly holds 35,176 FMC common shares. This total includes the 107 new shares issued through dividend equivalent rights attached to previously granted and now vested restricted stock units.

What are dividend equivalent rights in the FMC (FMC) filing?

Dividend equivalent rights provide additional shares or value mirroring dividends on underlying equity awards. In this case, FMC issued 107 common shares to Johnson KLynne as dividend equivalents on vested restricted stock units already held as part of director compensation.

Does the FMC (FMC) Form 4 indicate any insider selling activity?

The Form 4 shows only an acquisition, not a sale. Johnson KLynne received 107 FMC common shares as a grant via dividend equivalent rights, and there were no dispositions or open-market sales reported in this particular filing.